Incidence and sociodemographic characteristics of eczema diagnosis in children: A cohort study - 04/05/18
Doi : 10.1016/j.jaci.2017.12.997
Lu Ban, PhD a, b 
, Sinéad M. Langan, PhD c, Katrina Abuabara, MD d, Kim S. Thomas, PhD a, Alyshah Abdul Sultan, PhD b, e, Tracey Sach, PhD f, Emma McManus, MSc f, Miriam Santer, PhD g, Sonia Ratib, PhD a
, Sinéad M. Langan, PhD c, Katrina Abuabara, MD d, Kim S. Thomas, PhD a, Alyshah Abdul Sultan, PhD b, e, Tracey Sach, PhD f, Emma McManus, MSc f, Miriam Santer, PhD g, Sonia Ratib, PhD a a Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, United Kingdom
b NIHR Nottingham Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, United Kingdom
c Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom
d Department of Dermatology, University of California, San Francisco (UCSF), San Francisco, Calif
e Arthritis Research UK Primary Care Centre, Research Institute for Primary Care & Health Sciences, Keele University, Staffordshire, United Kingdom
f Health Economics Group, University of East Anglia, Norwich, United Kingdom
g Primary Care & Population Sciences, University of Southampton, Southampton, United Kingdom
| This work has been internally funded by the University of Nottingham. T.S. holds a Career Development Fellowship (CDF-2014-07-006) supported by the National Institute for Health Research (NIHR). S.M.L. was funded by an NIHR Clinician Scientist award (NIHR/CS/010/014) and is currently funded by a Wellcome Trust Senior Clinical Fellowship in Science (205039/Z/16/Z). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR, National Health Service, or the Department of Health. |
|
| Disclosure of potential conflict of interest: S. M. Langan's institution received a grant. S. M. Langan was funded by a National Institute for Health Research Clinician Scientist award (NIHR/CS/010/014) and is currently funded by a Wellcome Trust Senior Clinical Fellowship in Science for this work (205039/Z/16/Z). The rest of the authors declare that they have no relevant conflicts of interest. |
© 2018
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 141 - N° 5
P. 1927 - mai 2018 Retour au numéro
Article précédent
- New human combined immunodeficiency caused by interferon regulatory factor 4 (IRF4) deficiency inherited by uniparental isodisomy
- María Bravo García-Morato, Francisco Javier Aracil Santos, Alejandro Contreras Briones, Alfonso Blázquez Moreno, Ángela del Pozo Maté, Ángeles Domínguez-Soto, María José Beato Merino, Lucía del Pino Molina, Juan Torres Canizales, Ana Victoria Marin, Elena Vallespín García, Marta Feito Rodríguez, Diego Plaza López Sabando, Anaïs Jiménez-Reinoso, Yasmina Mozo del Castillo, Francisco José Sanz Santaeufemia, Raúl de Lucas-Laguna, Paula P. Cárdenas, Laura Casamayor Polo, María Coronel Díaz, Mar Valés-Gómez, Ernesto Roldán Santiago, Antonio Ferreira Cerdán, Julián Nevado Blanco, Ángel L. Corbí, Hugh T. Reyburn, José Ramón Regueiro, Eduardo López-Granados, Rebeca Rodríguez Pena
- Group 2 innate lymphoid cells promote airway hyperresponsiveness through production of VEGFA
- Xiaofei Shen, Muhammad Asghar Pasha, Kelsi Hidde, Adil Khan, Mingwei Liang, Wenxian Guan, Yitao Ding, Angela Haczku, Qi Yang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?